Vanda Pharmaceuticals (VNDA) Invested Capital (2016 - 2025)
Historic Invested Capital for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q3 2025 value amounting to $466.0 million.
- Vanda Pharmaceuticals' Invested Capital fell 1389.89% to $466.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $466.0 million, marking a year-over-year decrease of 1389.89%. This contributed to the annual value of $543.5 million for FY2024, which is 25.77% down from last year.
- According to the latest figures from Q3 2025, Vanda Pharmaceuticals' Invested Capital is $466.0 million, which was down 1389.89% from $486.3 million recorded in Q2 2025.
- In the past 5 years, Vanda Pharmaceuticals' Invested Capital registered a high of $544.9 million during Q4 2023, and its lowest value of $466.0 million during Q3 2025.
- Its 5-year average for Invested Capital is $515.8 million, with a median of $515.7 million in 2022.
- Per our database at Business Quant, Vanda Pharmaceuticals' Invested Capital skyrocketed by 1230.61% in 2021 and then plummeted by 1389.89% in 2025.
- Quarter analysis of 5 years shows Vanda Pharmaceuticals' Invested Capital stood at $504.9 million in 2021, then grew by 4.41% to $527.2 million in 2022, then rose by 3.36% to $544.9 million in 2023, then fell by 0.26% to $543.5 million in 2024, then decreased by 14.26% to $466.0 million in 2025.
- Its Invested Capital stands at $466.0 million for Q3 2025, versus $486.3 million for Q2 2025 and $511.4 million for Q1 2025.